Raygoza N. P, Salazar C. S, Olivos E. N, Luna M. D. J. G, Vazquez F. J. M, Martínez D. A. D. Description of Confirmed Cases and Deaths from COVID-19 in Mexico, Until May 6, 2020: an Ecological Study. Biomed Pharmacol J 2020;13(3).
Manuscript received on :19-May-2020
Manuscript accepted on :26-Aug-2020
Published online on: --
Plagiarism Check: Yes
Reviewed by: Dhananjay Deshmukh
How to Cite    |   Publication History
Views Views: (Visited 239 times, 1 visits today)   Downloads PDF Downloads: 298

Nicolás Padilla-Raygoza1*, Cuauhtémoc Sandoval-Salazar2, Efraín Navarro-Olivos3, María de Jesús Gallardo-Luna4, Francisco J. Magos-Vazquez5, Daniel Alberto Díaz-Martínez6

1 School of Medicine, University of Celaya, Mexico,

2 Department of Nursing and Obstetrics, Division of Health Sciences and Engineering, Campus Celaya-Salvatierra, University of Guanajuato, México,

3 Secretary of Health from Guanajuato State. México,

Corresponding Author E-mail: npadilla@udec.edu.mx

DOI : https://dx.doi.org/10.13005/bpj/2019

Abstract

A review is made of the confirmed cases of COVID-19 and deaths in Mexico as of May 6, 2020, from the public database of the General Directorate of Epidemiology and the National System of Epidemiological Surveillance of the Ministry of Health in Mexico. A descriptive ecological study of confirmed cases and deaths by COVID-19 is designed. 27,634 confirmed cases and 2,704 registered deaths were reviewed. Of the confirmed cases they predominated in men (58.48%) and their distribution by states of Mexico, being more frequent in Mexico City, State of Mexico, Baja California and Tabasco. Deaths are shown by day on which they occurred. It is concluded that the measures of social isolation and quarantine should be reinforced to decrease the number of confirmed cases and deaths related to COVID-19.

Keywords

COVID-19; Mexican Population; SARS-CoV2

Download this article as: 
Copy the following to cite this article:

Raygoza N. P, Salazar C. S, Olivos E. N, Luna M. D. J. G, Vazquez F. J. M, Martínez D. A. D. Description of Confirmed Cases and Deaths from COVID-19 in Mexico, Until May 6, 2020: an Ecological Study. Biomed Pharmacol J 2020;13(3).

Copy the following to cite this URL:

Raygoza N. P, Salazar C. S, Olivos E. N, Luna M. D. J. G, Vazquez F. J. M, Martínez D. A. D. Description of Confirmed Cases and Deaths from COVID-19 in Mexico, Until May 6, 2020: an Ecological Study. Biomed Pharmacol J 2020;13(3). Available from: https://bit.ly/3k3sqqF

Introduction

As of December 8, 2019, several cases of pneumonia of unknown cause have been reported in Wuhan, Hubei Province, China1-3 most of the patients worked in or lived around the Huanan seafood market, where animals for sale also live4. On December 31, 2019, a case of pneumonia of unknown cause was reported at the World Health Organization (WHO) office in Whuan, China5.

On January 10, 2020, the first death reported in China occurs from this new infection and on January 13, 2020, the first case was reported outside of China, in Thailand6. The outbreak is declared a Public Health emergency of international interest on January 30, 20205.

Idiopathic pneumonia is reported to be caused by a new coronavirus on February 7 and the WHO named it 2019-nCoV7. The new disease caused by coronavirus was named COVID-19 on February 11, 20205.

After a month, the virus was isolated, its genome was sequenced and its morphology was described; on January 12, 2020, the virus genome was shared with WHO by the Chinese Center for Disease Control and Prevention8. Zhou et al,9 reported that the causer of COVID-19 shares 79.5% of the SARS-CoV sequence; also, it uses the same cell entry receptor, angiotensin-converting enzyme-2, as SARS-CoV.

Zhu e t al.10, reported the cytopathic effects and morphology and it is a member of a family of coronaviruses that infect humans; grew more in human airway epithelial cells than tissue culture cells, suggesting the potential for increased infectivity.

In Mexico, the follow-up of cases begins at the end of January, by February 20, 2020 the first confirmed case was reported and by March 23, 405 cases had been confirmed in the country11 and by 28 of the same month 848 cases had been confirmed12. All cases at the beginning traveled to United States of America, Spain or Italy, no one traveled to China11.

The objective is to describe the confirmed cases of COVID-10 as well as the mortality due to COVID-19 in the Mexican population.

Material and Methods

A descriptive ecological study was designed with public data on confirmed, suspected and deceased cases by COVID-19 from the General Directorate of Epidemiology and the National System of Epidemiological Surveillance of the Ministry of Health of Mexico13.

Data on age, gender, state of residence, date of onset of symptoms, date of death were collected if it occurred. The date of positive test is missing in database.

For the statistical analysis, frequencies and percentages of categorical variables and mean and standard deviation were used for quantitative variables.

The STATA ® 13.0 program (Stata Corp., College Station, TX, USA) was used.

Results

Public records of confirmed cases of SARS-CoV-2 infection giving COVID-19 were 27,634 records.

Age range from 0 to 113 years with a mean of 46.72 ± 15.62 years. Table 1 shows the distribution by gender and by state reported by confirmed cases.

Table 1: Confirmed cases by gender and residence state (n=27,634)

Variable n %
Gender

Female

Male

 

11,475

16,159

 

41.52

58.48

States
   Aguascalientes 292 1.06
   Baja California 2,097 7.59
   Baja California Sur 358 1.30
   Campeche 147 0.53
   Coahuila de Zaragoza 491 1.78
   Colima 31 0.11
   Chiapas 263 0.95
   Chihuahua 600 2.17
   Cd Mexico 7,521 27.22
   Durango 91 0.33
   Guanajuato 343 1.24
   Guerrero 413 1.49
   Hidalgo 396 1.43
   Jalisco 492 1.78
   Mexican State 4,661 16.87
   Michoacán de Ocampo 423 1.53
   Morelos 612 2.21
   Nayarit 151 0.55
   Nuevo León 511 1.85
   Oaxaca 202 0.73
   Puebla 910 3.29
   Querétaro 179 0.65
   Quintana Roo 980 3.55
   San Luis Potosí 187 0.68
   Sinaloa 1,248 4.52
   Sonora 342 1.24
   Tabasco 1,319 4.77
   Tamaulipas 415 1.50
   Tlaxcala 280 1.01
   Veracruz Ignacio de la   Llave 872 3.16
   Yucatán 688 2.49
   Zacatecas 119 0.43
Total 27,634 100.0

Source: Secretary of Health [13]

Figure 1 shows the map of Mexico with names of the states.

Figure 1: Map of Mexico Figure 1: Map of Mexico

Click her to view figure

By May 6, 2020, 27,634 confirmed cases had been reported, higher than 848 cases reported on March 28, 2020, corresponding on average to an increase of 83.56% cases per day in that period. Despite noticing a decrease in confirmed cases in the first days of May 2020, it is considered an artifact due to the delay in delivering the results of the Real Time-PCR test.

Figure 2 shows the curve of accumulated cases as of May 6, 2020.

Figure 2: Distribution of confirmed cases by day (n=27,634)[13] Figure 2: Distribution of confirmed cases by day (n=27,634)[13]

Click here to view figure

Source: Secretary of Health [13]

Figure 3 shows the deaths reported by COVID-19 per day. On March 28, 200, a specific mortality rate of 1.9% was reported, with 16 deaths among 848 confirmed cases. For May 6, 2020, the specific mortality rate was 9.8% with 2704 deaths among 27,634 confirmed cases.

Figure 3: Distribution of deaths by day (n=2,704)[13] Figure 3: Distribution of deaths by day (n=2,704)[13]

Click here to view figure

Source: Secretary of Health [13]

Discussion

Of the 27,634 confirmed cases in Mexico as of May 6, 2020, men predominated slightly with 58.38% and the states with the highest frequency were: Mexico City (27.22%), State of Mexico (16.87%), Baja California (7.59% ), Tabasco (4.77%) and Sinaloa (4.52%) (Table 1).

In the public data of the General Directorate of Epidemiology, of the National Epidemiological Surveillance System of the Ministry of Health of Mexico, on March 23, 202014, the first confirmed case started with symptoms on February 20, 2020; in the database of May 6, 202013, several cases with symptom onset were reported on January 8, 14, 15 and 17, 2020. One reason is the delay in the result of the RT-PCR tests. Each state health system must report each case to the federal health system.

In mid-March, some state governments such as Guanajuato, Jalisco, among others, began to restrict the meetings of more than 10 people, cancel massive events, and by March 23, social isolation measures had been implemented and school activities were suspended at all levels, with the aim of reducing community transmission of SARS-CoV-2.

Sanche et al.15, they estimated a serial interval of 6 to 9 days and calculated R0 of 5.7, so they recommended active surveillance, contact surveillance, quarantine and strong social distancing to stop the transmission of the virus. If one case can infect almost six more people, the spread of the infection will continue to appear in the community. Quarantine and social isolation aim to decrease this Ro.

Analyzing the confirmed cases from March 23 to May 6, 2020 in Mexico, it is found that there was an increase in cases from 405 to 27,634, in 43 days, with an average of 158.67% per day of increase in cases per day, much higher than Italy and to Spain with an average and increase in confirmed cases of 25 and 20%, respectively16.

Bulut et al.17, report that accord to early models total 10-12 weeks is required to control an outbreak in the community, but in all countries affected by COVID-19 is needed more than 12 week to flatted the epi.curve of new cases.

Matrajt et al.18, reported that after social distancing interventions, 20% of new cases and most hospitalizations were averted, but to the end of intervention, the epidemic rebounded. Similar conclusion reported by Li et al.19, imposing social controls impact the number of new cases.

Regarding mortality, Mexico reported 5 deaths on March 2420, and for May 6, 2020, the registered deaths were 2,704, with an average daily increase of 1.257% in specific mortality. The specific mortality rate for Mexico, as of May 6, 2020, was 9.8% higher than that reported by the PAHO on the same day of 7.11%21.

With the figures of confirmed cases and deaths in Mexico, they confirm that the social isolation and the quarantine established by the health authorities have not produced a decrease in new cases. The massive campaigns launched targeting the general population, to stay home, wear protection (face masks) and wash your hands have not produced the expected results.

Conclusión

Although quarantine and social isolation were implemented more than a month ago, the number of confirmed cases in Mexico continues to grow. Social isolation measures and a healthy distance between people must be reinforced.

Conflict of interest

Nothing to declare

Funding source

No one

References

  1.  Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4):401-402.  Doi: https://doi.org/10.1002/jmv.25678
  2. Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O,  et al. The continuing 2019-nCoV epidemic threatof novel coronaviruses to global health – the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020; 91: 264-66 Doi: https://doi.org/10.1016/j.ijid.2020.01.009
  3. Huang C, Wang Y, Li X, Ren L, Zhao J, Yi  Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506    Doi: https://doi.org/10.1016/S0140-6736(20)30183-5
  4. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-13      https://doi.org/10.1016/S0140-6736(20)30211-7
  5. World Health Organization. Rolling updates on coronavirus disease (COVID-19). Updated 7 May 2020. Available in: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
  6. Yoo JH, Hong ST. The outbreak caseswith the novel coronavirus suggest upgraded quarantine and isolation in Korea. J Korean Med Sci. 2020;35(5): e62 Doi: https://doi.org/10.3346/jkms.2020.35.e62
  7. Carlos WG, Dela Cruz C, Cao B, Pasnick S, Jamil S, Novel Wuhan (2019-CoV) coronavirus. Am J Respi Crit Care Med 2020;201(4):7-8 Doi: https://doi.org/10.1164/rccm.2014P7
  8. Zhang Y, Ku J, Li H, Cao B. A novel coronavirus (COVID-19) outbreak. A call for action. Chest. 2020;157(4):e99-e101. Doi: https://doi.org/10.1016/j.chest.2020.02.014
  9. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-3.     https://doi.org/10.1038/s41586-020-2012-7
  10. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382:727:37. Doi: https://doi.org/10.1056/NEJMoa2001017
  11. National System of Surveillance Epidemiological. General Directorate of Epidemiology. Secretary of Health. Confirmed cases to disease by COVID-19. 2020. Available in: https://www.gob.mx/cms/uploads/attachment/file/543205/Tabla_casos_positivos_COVID-19_resultado_InDRE_2020.03.24.pdf
  12. National System of Surveillance Epidemiological. General Directorate of Epidemiology. Secretary of Health. Confirmed cases to disease by COVID-19. 2020. Available in: https://www.gob.mx/cms/uploads/attachment/file/544029/Tabla_casos_positivos_COVID-19_resultado_InDRE_2020.03.28.pdf
  13. Secretary of Health. Open data. Historic databases. May 6, 2020. Availablein: https://www.gob.mx/salud/documentos/datos-abiertos-bases-historicas-direccion-general-de-epidemiologia
  14. National System of Surveillance Epidemiological. General Directorate of Epidemiology. Secretary of Health. Confirmed cases to disease by COVID-19. 2020. Available in: https://www.gob.mx/cms/uploads/attachment/file/543205/Tabla_casos_positivos_COVID-19_resultado_InDRE_2020.03.24.pdf
  15. Sanche S, Lin YT, Romero-Severson E, Hengartner N,  Ke R. High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2020; 26(7): 1470-1477. Doi: https://doi.org/10.3201/eid2607.200282
  16. Cordova-Lepe F, Gutiérrez-Aguilar R, Gutiérrez-Jara JP. Number of COVID-19 cases in Italia at 120 days with data at 21/03/2020 and threshold of daily effort to flatten the epi-curve. Medwave 2020;20(2):e7861 Doi: http://doi.org/10.5867/medwave.2020.02.7861
  17. Bulut C, Kato Y. Epidemiology of COVID-19 Turk J Med Sci. 2020;50(S1-1): 563-570. Doi: http://doi.org/10.3906/sag-2003-172
  18. Matrajt L, Leung T. Evaluating the effectiveness of social distancing interventions to delay or flatten the epidemic curve of Coronavirus disease. Emerg. Infect. Dis. 2020; 26(8). Doi: http://doi.org/10.3201/eid2608.201093
  19. Li L, Yang Z, Dang Z, Meng C, Huang J, Meng H, et al. Propagation analysis and prediction of the COVID-19. Infectious Disease Modelling. 2020; 3: 282-292. Doi: http://doi.org/10.1016/j.idm.2020.03.002
  20. Unidad de Inteligencia Epidemiológica y Sanitaria. Secretaría de Salud. Comunicado técnico diario nuevo Coronavirus en el Mundo (COVID-19). 2020. Cited: March 25, 2020. Available in: https://www.gob.mx/cms/uploads/attachment/file/543207/Comunicado_Tecnico_Diario_COVID-19_2020.03.24.pdf
  21. PanAmerican Health Organization.  COVID-19. Novel coronavirus 2019. Updated 6 May 2020. Available in: https://www.paho.org/arg/index.php?option=com_docman&view=download&alias=489-actualizacion-covid-19-6-de-mayo-de-2020&category_slug=actualizaciones&Itemid=624
Share Button
(Visited 239 times, 1 visits today)

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.